Skip to main content

Gamida Cell Ltd.

GMDADelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001600847

Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.

Q3 2022 vs. Q2 2022

How the institutions holding Gamida Cell Ltd. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of GMDA: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders5762+5
Shares14.4M23.5M+9.13M (+63.4%)
Value$25.8M$38.3M+$12.5M (+48.6%)

New holders (11)

Institutions that held Gamida Cell Ltd. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to GMDA in Q3 2022
InstitutionSharesValue% of portfolio
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD2,211,981$3.80M0.32%
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD801,843$1.38M0.32%
DAFNA Capital Management LLC614,896$978.0K0.26%
XTX Topco Ltd62,084$99.0K0.02%
Levin Capital Strategies, L.P.25,000$40.0K0.01%
Citadel Advisors LLC25,350$40.0K0.00%
Occudo Quantitative Strategies LP15,108$24.0K0.00%
Schonfeld Strategic Advisors LLC11,400$18.0K0.00%
Balyasny Asset Management LLC10,424$17.0K0.00%
Axiom Investment Management LLC500$1.00K0.00%
China Universal Asset Management Co., Ltd.561$1.00K0.00%

Sold out (6)

Institutions that held Gamida Cell Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of GMDA in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Highbridge Capital Management LLC1,197,875$2.12M
ARK Investment Management LLCSuperinvestorARK Invest714,534$1.56M
State Street Corp73,987$131.0K
Steward Partners Investment Advisory, LLC500$1.00K
Newbridge Financial Services Group, Inc.378$1.00K
International Biotechnology Trust PLC187–